In the BioHarmony Drug Report Database

"Preview" Icon

Conestat alfa

Ruconest (conestat alfa) is a protein pharmaceutical. Conestat alfa was first approved as Ruconest on 2010-10-28. It has been approved in Europe to treat hereditary angioedemas.

 

Trade Name

 

Ruconest
 

Common Name

 

conestat alfa
 

ChEMBL ID

 

CHEMBL2108350
 

Indication

 

hereditary angioedemas
 

Drug Class

 

Enzyme inhibitors

Image (chem structure or protein)

Conestat alfa structure rendering